具有佐剂效果的海藻酸钙纳米胶囊制备

利用海藻酸多糖酸沉淀性质并结合乳化技术，本研究开发了一种酸沉淀诱导相变制备海藻酸钙纳米胶囊的新颖方法，并通过改变海藻酸钠溶液和表面活性剂浓度获得了最小平均水动力学直径在300 nm以下的球形凝胶颗粒，粒径分布均一，表面呈负电性。细胞培养实验结果表明，该海藻酸钙纳米胶囊对人外周血来源未成熟树突状细胞的成熟有与肿瘤坏死因子?（TNF-?）和细菌脂多糖（LPS）相当效力的刺激作用。蛋白质分子可通过共价偶联方式负载。该海藻酸钙纳米胶囊在新型疫苗设计、细胞治疗和靶向给药等方面具有重要的应用潜力。

Preparation of Calcium Alginate Nanocapsules with Adjuvant Effect

A novel reverse emulsification-phase transition process was designed to prepare alginate-based nanocapsules in the present study. Ca alginate nanocapsules with an average hydrodynamic diameter below 300 nm were obtained by adjusting surfactant and alginate concentration. Instrumental analysis observations revealed a morphologically spherical shape with a relatively uniform size distribution without aggregation. -potential measurements indicated an topically electrostatically negative nature of capsules in neutral aqueous solution. These nanocapsules were proven to have an equivalent potency to stimulate the maturation of dendritic cells originated from CD14 positive cells isolated from human peripheral blood. Protein loading via covalent conjugation was demonstrated feasible with EDC/NHS facilitated reaction between carboxyl and amino groups. These nanocapsules are considered to have important applications as a new adjuvant in cancer cell therapy, vaccine design and targeted drug delivery for active components of protein nature.